Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-03-16

Clinical Trial Update: Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder Symptoms [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating transcutaneous electrical nerve stimulation for overactive bladder was withdrawn, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcutaneous electrical nerve stimulation (TENS) device for overactive bladder (transcutaneous electrical nerve stimulation)

Snippet

Sponsor: Meir Medical Center | Conditions: Overactive Bladder | Phase 2 | Status: WITHDRAWN